Get the Stockscreener App
0.32
2.89%
0.009
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Latest News
After Jumping 10.61% During The Past Week, Should You Still Buy Recursion Pharmaceuticals Inc (NASDAQ: RXRX)? - Marketing Sentinel
Beyond Inc (NYSE: BYON) Has Succeeded In Generating Interest In 2025, The Stock Is Up 87.02% Year-To-Date - Marketing Sentinel
Should You Expect A Quick Recovery From Personalis Inc (NASDAQ: PSNL) After -35.08% Decline From High? - Marketing Sentinel
Market cap of Captivision Inc [CAPT] reaches 33.99M – now what? - The DBT News
Citigroup lifts StoneCo Ltd [STNE] price estimate. Who else is bullish? - The DBT News
Quoin Pharmaceuticals launches Netherton awareness campaign - Investing.com India
Understanding QNRX’s financial ratios: A beginner’s guide - US Post News
Earnings call transcript: Quoin Pharmaceuticals Q4 2023 sees stock volatility - MSN
Quoin Pharma's Netherton Syndrome Treatment Shows Strong Results, Requires Continuous Use - StockTitan
Quoin reports progress in pediatric skin disorder study - Investing.com
PRISM MarketView Spotlights Quoin Pharmaceuticals CEO Dr. Michael Myers as Specialty Pharma Shares News of Highly Positive Interim Data in Most Advanced, Comprehensive Netherton Syndrome Trials - GlobeNewswire Inc.
Quoin Pharmaceuticals reports positive trial results for skin treatment - Investing.com
Quoin reports positive results in Netherton Syndrome study - Investing.com
Quoin Pharmaceuticals CFO Dunn Gordon buys $54,999 in shares - Investing.com India
Quoin Pharmaceuticals CEO Michael Myers acquires $250,000 in shares By Investing.com - Investing.com South Africa
Quoin Pharmaceuticals director Anthony Culverwell buys $45,000 in shares - Investing.com India
Quoin Pharmaceuticals COO Denise Carter buys $250,000 in shares - Investing.com India
Quoin Pharmaceuticals COO Denise Carter buys $250,000 in shares By Investing.com - Investing.com South Africa
Quoin Pharmaceuticals director Anthony Culverwell buys $45,000 in shares By Investing.com - Investing.com South Africa
Quoin Pharmaceuticals CFO Dunn Gordon buys $54,999 in shares By Investing.com - Investing.com South Africa
Quoin Pharmaceuticals sets terms for public offering - Investing.com
Quoin Pharmaceuticals advances Netherton Syndrome study - Investing.com India
Quoin Pharmaceuticals amends shareholder rights, adjusts executive compensation - Investing.com India
Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2024 Financial Results - Yahoo Finance
Quoin Pharmaceuticals advances Netherton syndrome treatment trial - Investing.com
Quoin Pharmaceuticals granted extension to meet Nasdaq listing - Investing.com India
Quoin Pharmaceuticals expands UK clinical trials for rare disease - Investing.com
Quoin Pharmaceuticals sets date for 2024 shareholder meeting - Investing.com
Balance Sheet Insights: Quoin Pharmaceuticals Ltd ADR (QNRX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Quoin Pharmaceuticals CFO buys shares worth over $23,000 - Investing.com
Healthy Upside Potential: Quoin Pharmaceuticals Ltd ADR (QNRX) - SETE News
A closer look at QNRX’s price-to-free cash flow ratio - US Post News
Quoin Pharmaceuticals COO acquires $28,737 in company shares - Investing.com
Quoin Pharmaceuticals CEO acquires shares worth over $28k - Investing.com
Quoin Pharmaceuticals (NASDAQ:QNRX) Stock Quotes, Forecast and News Summary - Benzinga
QNRX Stock Hits 52-Week Low at $0.57 Amid Market Challenges - Investing.com Australia
GLMD Stock Quote Price and Forecast - CNN
symbol__ Stock Quote Price and Forecast - CNN
Earnings call: Quoin Pharmaceuticals reports Q4 progress and outlook By Investing.com - Investing.com South Africa
Why Quoin Pharmaceuticals (QNRX) Shares Are Nosediving - Benzinga
Major Indexes Muted Following Strong Jobs Report - Schaeffers Research
ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):